Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

The impact of MDA on hookworm prevalence and intensity of infection stratified by treatment with IDA or DA. by Jannet A. Tobon Ramos (20855642)

<i>PsnWRKY95</i> transgenic plants selection and functional analysis of <i>PsnWRKY95</i> in cadmium resistance. by Yuzhao Ma (12840632)

Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”

NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Master database baseline, 4 weeks and 1 year. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Breaking strength and ash contents in the tibia. by Miloš Skřivan (5122037)

Subjects:

Supporting information. by Yu Sang Choi (22656230)

Subjects:

Composition and nutrient contents of the basal diet^a. by Miloš Skřivan (5122037)

Subjects: